%K antiviral drugs, integrase inhibitors, mechanism of action, nucleoside and nucleotide reverse transcriptase inhibitors, protease inhibitors, viral infections.
%D 2024
%R oai:ojs.pkp.sfu.ca:article/731
%T CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS
%A Ergashev Asilbek Qudrat oʻgʻli
%A Abdunazarov Azimjon Alisher oʻgʻli
%A Chariev Muzaffar Yuldashevich
%J Multidisciplinary Journal of Science and Technology
%O Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/731)
%L arxiv52939
%I Center for Tech and Media Research
%X This article discusses the clinical pharmacology, mechanism of action, time of action, types and composition of antiviral drugs. The article introduces new antiviral drugs being developed in the pharmaceutical industry, their pharmacotherapeutic groups, international non-patented names, and the country of manufacture. Nowadays, the need for antiviral drugs is increasing. Because it is the time when seasonal viral diseases and allergies are on the rise and immunity decreases to a certain extent. Therefore, we will get acquainted with the new anti-viral drugs included in the State Register.